ESR1 and breast cancer: Taken together, these findings suggest that S-palmitoylation of MTDH enhances ferroptosis sensitivity in breast cancer cells, may particularly in MDA-MB-231, but not in estrogen receptor-positive (ER+) MCF7 cells.